Ustk y LES

Ustekinumab May Provide Sustained Clinical Benefits Through One Year In Patients With SLE, Study Suggests

Healio (12/26, Laday) reports researchers found that "ustekinumab provides sustained clinical benefits through 1 year among patients with systemic lupus erythematosus [SLE], with a safety profile similar with its other indications." The findings were published in Arthritis & Rheumatology

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.